Patents by Inventor Andrei Tokmakoff

Andrei Tokmakoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170313736
    Abstract: The present disclosure provides nucleoside analogs of Formula (I) or (II). The nucleoside analogs are expected to show multiple tautomerism and may increase the mutation of an RNA and/or DNA (be mutagenic) of a virus or cancer cell. The multiple tautomerism and mutagenesis of the nucleoside analogs may be adjusted by substituting the nucleoside analogs with one or more electron-donating groups and/or electron-withdrawing groups to increase or decrease the pKa (e.g., to a pKa between 5.5 or 8.5). The present disclosure also provides pharmaceutical compositions and kits including the nucleoside analogs and methods of treating a viral infection (e.g., influenza, HIV infection, or hepatitis) or cancer using the nucleoside analogs, pharmaceutical compositions, or kits.
    Type: Application
    Filed: July 6, 2017
    Publication date: November 2, 2017
    Applicant: Massachusetts Institute of Technology
    Inventors: John M. Essigmann, Andrei Tokmakoff, Bogdan I. Fedeles, Vipender Singh, Chunte Peng
  • Patent number: 9714265
    Abstract: The present disclosure provides nucleoside analogs of Formula (I) or (II). The nucleoside analogs are expected to show multiple tautomerism and may increase the mutation of an RNA and/or DNA (be mutagenic) of a virus or cancer cell. The multiple tautomerism and mutagenesis of the nucleoside analogs may be adjusted by substituting the nucleoside analogs with one or more electron-donating groups and/or electron-withdrawing groups to increase or decrease the pKa (e.g., to a pKa between 5.5 or 8.5). The present disclosure also provides pharmaceutical compositions and kits including the nucleoside analogs and methods of treating a viral infection (e.g., influenza, HIV infection, or hepatitis) or cancer using the nucleoside analogs, pharmaceutical compositions, or kits.
    Type: Grant
    Filed: January 28, 2016
    Date of Patent: July 25, 2017
    Assignee: Massachusetts Institute of Technology
    Inventors: John M. Essigmann, Andrei Tokmakoff, Bogdan I. Fedeles, Vipender Singh, Chunte Peng
  • Patent number: 9476768
    Abstract: The present invention relates to a system and methods for acquiring two-dimensional Fourier transform (2D FT) spectra. Overlap of a collinear pulse pair and probe induce a molecular response which is collected by spectral dispersion of the signal modulated probe beam. Simultaneous collection of the molecular response, pulse timing and characteristics permit real time phasing and rapid acquisition of spectra. Full spectra are acquired as a function of pulse pair timings and numerically transformed to achieve the full frequency-frequency spectrum. This method demonstrates the ability to acquire information on molecular dynamics, couplings and structure in a simple apparatus. Multi-dimensional methods can be used for diagnostic and analytical measurements in the biological, biomedical, and chemical fields.
    Type: Grant
    Filed: July 31, 2013
    Date of Patent: October 25, 2016
    Assignee: Massachusetts Institute of Technology
    Inventors: Lauren DeFlores, Andrei Tokmakoff
  • Publication number: 20160222050
    Abstract: The present disclosure provides nucleoside analogs of Formula (I) or (II). The nucleoside analogs are expected to show multiple tautomerism and may increase the mutation of an RNA and/or DNA (be mutagenic) of a virus or cancer cell. The multiple tautomerism and mutagenesis of the nucleoside analogs may be adjusted by substituting the nucleoside analogs with one or more electron-donating groups and/or electron-withdrawing groups to increase or decrease the pKa (e.g., to a pKa between 5.5 or 8.5). The present disclosure also provides pharmaceutical compositions and kits including the nucleoside analogs and methods of treating a viral infection (e.g., influenza, HIV infection, or hepatitis) or cancer using the nucleoside analogs, pharmaceutical compositions, or kits.
    Type: Application
    Filed: January 28, 2016
    Publication date: August 4, 2016
    Inventors: John M. Essigmann, Andrei Tokmakoff, Bogdan I. Fedeles, Vipender Singh, Chunte Peng
  • Patent number: 9222881
    Abstract: The present invention relates to systems and methods for the determination of the secondary structure composition of proteins using coherent two-dimensional infrared (2DIR) spectroscopy of backbone amide I vibrations (1580-1720 cm?1). Fractions of ?-helix, ?-sheet, and unassigned regions in globular proteins were determined by singular value decomposition using basis spectra from sixteen commercially-available proteins with known crystal structures. Preferred methods included removing each protein from the set and comparing the predicted composition against the crystal structure. The root-mean-squared (RMS) errors of the predicted secondary structure compositions were found to be 7.9% for ?-helix, 5.5% for ?-sheet, and 7.6% for unassigned regions. The structure analysis can also be performed using one-dimensional absorption spectra and the RMS errors are compared with those obtained from 2DIR.
    Type: Grant
    Filed: February 24, 2012
    Date of Patent: December 29, 2015
    Assignee: Massachusetts Institute of Technology
    Inventors: Carlos R. Baiz, Kevin C. Jones, Andrei Tokmakoff
  • Publication number: 20130314702
    Abstract: The present invention relates to a system and methods for acquiring two-dimensional Fourier transform (2D FT) spectra. Overlap of a collinear pulse pair and probe induce a molecular response which is collected by spectral dispersion of the signal modulated probe beam. Simultaneous collection of the molecular response, pulse timing and characteristics permit real time phasing and rapid acquisition of spectra. Full spectra are acquired as a function of pulse pair timings and numerically transformed to achieve the full frequency-frequency spectrum. This method demonstrates the ability to acquire information on molecular dynamics, couplings and structure in a simple apparatus. Multi-dimensional methods can be used for diagnostic and analytical measurements in the biological, biomedical, and chemical fields.
    Type: Application
    Filed: July 31, 2013
    Publication date: November 28, 2013
    Inventors: Lauren DeFlores, Andrei Tokmakoff
  • Patent number: 8526002
    Abstract: The present invention relates to a system and methods for acquiring two-dimensional Fourier transform (2D FT) spectra. Overlap of a collinear pulse pair and probe induce a molecular response which is collected by spectral dispersion of the signal modulated probe beam. Simultaneous collection of the molecular response, pulse timing and characteristics permit real time phasing and rapid acquisition of spectra. Full spectra are acquired as a function of pulse pair timings and numerically transformed to achieve the full frequency-frequency spectrum. This method demonstrates the ability to acquire information on molecular dynamics, couplings and structure in a simple apparatus. Multi-dimensional methods can be used for diagnostic and analytical measurements in the biological, biomedical, and chemical fields.
    Type: Grant
    Filed: September 8, 2008
    Date of Patent: September 3, 2013
    Assignee: Massachusetts Institute of Technology
    Inventors: Lauren DeFlores, Andrei Tokmakoff
  • Publication number: 20130221222
    Abstract: The present invention relates to systems and methods for the determination of the secondary structure composition of proteins using coherent two-dimensional infrared (2DIR) spectroscopy of backbone amide I vibrations (1580-1720 cm?1). Fractions of ?-helix, ?-sheet, and unassigned regions in globular proteins were determined by singular value decomposition using basis spectra from sixteen commercially-available proteins with known crystal structures. Preferred methods included removing each protein from the set and comparing the predicted composition against the crystal structure. The root-mean-squared (RMS) errors of the predicted secondary structure compositions were found to be 7.9% for ?-helix, 5.5% for ?-sheet, and 7.6% for unassigned regions. The structure analysis can also be performed using one-dimensional absorption spectra and the RMS errors are compared with those obtained from 2DIR.
    Type: Application
    Filed: February 24, 2012
    Publication date: August 29, 2013
    Inventors: Carlos R. Baiz, Kevin C. Jones, Andrei Tokmakoff
  • Patent number: 7812311
    Abstract: Preferred embodiments of the invention provide for methods and systems of 2D spectroscopy using ultrafast, first light and second light beams and a CCD array detector. A cylindrically-focused second light beam interrogates a target that is optically interactive with a frequency-dispersed excitation (first light) pulse, whereupon the second light beam is frequency-dispersed at right angle orientation to its line of focus, so that the horizontal dimension encodes the spatial location of the second light pulse and the first light frequency, while the vertical dimension encodes the second light frequency. Differential spectra of the first and second light pulses result in a 2D frequency-frequency surface equivalent to double-resonance spectroscopy. Because the first light frequency is spatially encoded in the sample, an entire surface can be acquired in a single interaction of the first and second light pulses.
    Type: Grant
    Filed: December 1, 2006
    Date of Patent: October 12, 2010
    Assignee: Massachusetts Institute of Technology
    Inventors: Matthew F. DeCamp, Andrei Tokmakoff
  • Publication number: 20100171952
    Abstract: The present invention relates to a system and methods for acquiring two-dimensional Fourier transform (2D FT) spectra. Overlap of a collinear pulse pair and probe induce a molecular response which is collected by spectral dispersion of the signal modulated probe beam. Simultaneous collection of the molecular response, pulse timing and characteristics permit real time phasing and rapid acquisition of spectra. Full spectra are acquired as a function of pulse pair timings and numerically transformed to achieve the full frequency-frequency spectrum. This method demonstrates the ability to acquire information on molecular dynamics, couplings and structure in a simple apparatus. Multi-dimensional methods can be used for diagnostic and analytical measurements in the biological, biomedical, and chemical fields.
    Type: Application
    Filed: September 8, 2008
    Publication date: July 8, 2010
    Inventors: Lauren DeFlores, Andrei Tokmakoff
  • Patent number: 7696479
    Abstract: The invention relates to methods and apparatus for modifying the frequency characteristics of a spatially-dispersed mid-IR spectra for spectroscopy. In a preferred embodiment, sum frequency generation between a frequency-dispersed IR beam and an ultrafast optical pulse generates a spatially-extended optical signal that is collected with a CCD detector.
    Type: Grant
    Filed: June 2, 2006
    Date of Patent: April 13, 2010
    Assignee: Massachusetts Institute of Technology
    Inventors: Matthew F. DeCamp, Andrei Tokmakoff
  • Publication number: 20070152154
    Abstract: Preferred embodiments of the invention provide for methods and systems of 2D spectroscopy using ultrafast, first light and second light beams and a CCD array detector. A cylindrically-focused second light beam interrogates a target that is optically interactive with a frequency-dispersed excitation (first light) pulse, whereupon the second light beam is frequency-dispersed at right angle orientation to its line of focus, so that the horizontal dimension encodes the spatial location of the second light pulse and the first light frequency, while the vertical dimension encodes the second light frequency. Differential spectra of the first and second light pulses result in a 2D frequency-frequency surface equivalent to double-resonance spectroscopy. Because the first light frequency is spatially encoded in the sample, an entire surface can be acquired in a single interaction of the first and second light pulses.
    Type: Application
    Filed: December 1, 2006
    Publication date: July 5, 2007
    Inventors: Matthew DeCamp, Andrei Tokmakoff
  • Publication number: 20070018103
    Abstract: The invention relates to methods and apparatus for modifying the frequency characteristics of a spatially-dispersed mid-IR spectra for spectroscopy. In a preferred embodiment, sum frequency generation between a frequency-dispersed IR beam and an ultrafast optical pulse generates a spatially-extended optical signal that is collected with a CCD detector.
    Type: Application
    Filed: June 2, 2006
    Publication date: January 25, 2007
    Inventors: Matthew DeCamp, Andrei Tokmakoff